Dna X (SONM) Payables (2018 - 2025)
Historic Payables for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $25.2 million.
- Dna X's Payables rose 17854.46% to $25.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.2 million, marking a year-over-year increase of 17854.46%. This contributed to the annual value of $22.8 million for FY2024, which is 1512.07% up from last year.
- Per Dna X's latest filing, its Payables stood at $25.2 million for Q3 2025, which was up 17854.46% from $23.5 million recorded in Q2 2025.
- Dna X's 5-year Payables high stood at $25.2 million for Q3 2025, and its period low was $8.1 million during Q2 2022.
- In the last 5 years, Dna X's Payables had a median value of $16.3 million in 2021 and averaged $16.2 million.
- As far as peak fluctuations go, Dna X's Payables tumbled by 6105.95% in 2024, and later surged by 17854.46% in 2025.
- Dna X's Payables (Quarter) stood at $9.5 million in 2021, then skyrocketed by 123.01% to $21.1 million in 2022, then decreased by 6.05% to $19.8 million in 2023, then rose by 15.12% to $22.8 million in 2024, then grew by 10.4% to $25.2 million in 2025.
- Its last three reported values are $25.2 million in Q3 2025, $23.5 million for Q2 2025, and $19.6 million during Q1 2025.